Patient Care

This page includes news coverage of various aspects of patient healthcare, including new technology innovations, what is working, what is not, personalized medicine and remote and telemedicine delivery. Find specific news in the areas of Care DeliveryDigital TransformationPrecision MedicineRemote Monitoring and Telehealth.

Thumbnail

Minding MACRA

Is MACRA the new SGR? Thankfully not. But that doesn’t mean you can ignore it.

Proton pump inhibitors may increase risk for MI

Patients who take proton pump inhibitors (PPIs) may be at an increased risk for myocardial infarction (MI) and other cardiovascular outcomes, according to a data mining analysis. However, there was no association between the use of H2 blockers and MI or cardiovascular risk. H2 blockers are alternatives to PPIs in treating gastroesophageal reflux disease.

Thumbnail

Cardiovascular network provides benefits beyond patient referrals

If the alliance between his health system in Texas and the Cleveland Clinic didn’t bring a single new patient through their doors, it would still be a victory, said Michael Mack, MD. “We’ve already received enough value that we view this as a success.”

FDA advisory panel recommends approval of second PCSK9 inhibitor in two days

An FDA advisory panel on June 10 recommended the approval of evolocumab, a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor intended to reduce low-density lipoprotein cholesterol and improve other lipids.

Thumbnail

Higher symptom burden correlates with decreased quality of life but not risk of death in AF patients

An analysis of a large, nationwide registry of patients with atrial fibrillation has delivered some counterintuitive results that could signal a needed change in healthcare utilization for such patients.

Panel recommends FDA approve PCSK9 inhibitor alirocumab

The FDA’s advisory panel voted 13-3 in favor of alirocumab as an anticholesterol treatment, paving the way for what might become the first fully human monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) in the U.S.

Thumbnail

N.Y. center pays $18.8M to settle case about cardiology referrals

A New York medical center paid almost $19 million to settle a kickback case involving a cardiology practice. The charges alleged that the medical center improperly paid the practice for referrals and improperly submitted cost reports for cardiology fellows’ services.

FDA panel to review evolocumab for hyperlipidemia and other indications

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee is scheduled to vote on June 10 on the safety and efficacy of evolocumab, an injectable medication to treat hyperlipidemia, mixed dyslipidemia and homozygous familial hypercholesterolemia.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.